Ticker | $ Bought |
---|---|
ionis pharmaceuticals, inc. | 29,543,600 |
grail, inc. | 29,097,700 |
candel therapeutics, inc. | 25,883,600 |
vir biotechnology, inc. | 7,960,520 |
intellia therapeutics, inc. | 7,510,390 |
biontech se | 5,131,280 |
disc medicine, inc. | 4,884,970 |
dbv technologies s.a. | 4,515,800 |
Ticker | % Inc. |
---|---|
structure therapeutics inc. | 322 |
ionis pharmaceuticals, inc. | 60.16 |
crispr therapeutics ag | 55.15 |
merus n.v. | 50.00 |
neurogene inc. | 47.9 |
celcuity inc. | 42.86 |
immunovant, inc. | 39.37 |
kala bio, inc. | 34.84 |
Ticker | % Reduced |
---|---|
biomea fusion, inc. | -31.15 |
sagimet biosciences inc. | -31.04 |
beigene, ltd. | -9.81 |
rhythm pharmaceuticals, inc. | -4.91 |
Ticker | $ Sold |
---|---|
dbv technologies s.a. | -5,114,990 |
alector, inc. | -4,321,050 |
tango therapeutics, inc. | -5,775,000 |
aerovate therapeutics, inc. | -1,314,480 |
crinetics pharmaceuticals, inc. | -5,310,670 |
newamsterdam pharma company n.v. | -1,605,400 |
biocryst pharmaceuticals, inc. | -575,913 |
pfizer inc. | -1,012,900 |
BAKER BROS. ADVISORS LP has about 96.7% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 96.7 |
Others | 3.3 |
BAKER BROS. ADVISORS LP has about 45.8% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
MID-CAP | 31.2 |
LARGE-CAP | 26.7 |
MEGA-CAP | 19.1 |
SMALL-CAP | 15.6 |
UNALLOCATED | 3.8 |
MICRO-CAP | 3.4 |
About 70.4% of the stocks held by BAKER BROS. ADVISORS LP either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
RUSSELL 2000 | 47.4 |
Others | 29.6 |
S&P 500 | 23 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
BAKER BROS. ADVISORS LP has 93 stocks in it's portfolio. About 76.5% of the portfolio is in top 10 stocks. BGNE proved to be the most loss making stock for the portfolio. MDGL was the most profitable stock for BAKER BROS. ADVISORS LP last quarter.
Last Reported on: 14 Feb, 2025Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
ABCL | abcellera biologics inc. | 0.86 | 27,525,600 | 80,650,100 | unchanged | 0.00 | ||
ACAD | acadia pharmaceuticals inc. | 8.40 | 42,877,900 | 786,810,000 | unchanged | 0.00 | ||
AKRO | akero therapeutics, inc. | 0.33 | 1,097,080 | 30,520,800 | unchanged | 0.00 | ||
ALEC | alector, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ALGS | aligos therapeutics, inc. | 0.04 | 83,055 | 3,308,910 | unchanged | 0.00 | ||
ALKS | alkermes plc | 1.28 | 4,181,750 | 120,267,000 | unchanged | 0.00 | ||
ARCT | arcturus therapeutics holdings inc. | 0.03 | 151,329 | 2,568,050 | unchanged | 0.00 | ||
ARVN | arvinas, inc. | 0.08 | 405,576 | 7,774,890 | unchanged | 0.00 | ||
AVTE | aerovate therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
BCRX | biocryst pharmaceuticals, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
BCYC | bicycle therapeutics plc | 1.63 | 10,885,400 | 152,395,000 | added | 15.8 | ||
BGNE | beigene, ltd. | 18.81 | 9,531,880 | 1,760,630,000 | reduced | -9.81 | ||
BMEA | biomea fusion, inc. | 0.06 | 1,451,990 | 5,633,720 | reduced | -31.15 | ||
CADL | candel therapeutics, inc. | 0.28 | 2,981,980 | 25,883,600 | new | |||
CELC | celcuity inc. | 0.38 | 2,678,550 | 35,062,300 | added | 42.86 | ||
CERS | cerus corporation | 0.32 | 19,477,300 | 29,995,100 | unchanged | 0.00 | ||
CLDX | celldex therapeutics, inc. | 0.07 | 247,644 | 6,257,960 | unchanged | 0.00 | ||
CMPX | compass therapeutics, inc. | 0.02 | 1,557,630 | 2,258,560 | unchanged | 0.00 | ||
CNTA | centessa pharmaceuticals plc | 0.22 | 1,227,180 | 20,555,200 | unchanged | 0.00 | ||
CRNX | crinetics pharmaceuticals, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||